SHL Stock Overview
Sonic Healthcare Limited offers medical diagnostic services in Australia.
Sonic Healthcare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$33.64|
|52 Week High||AU$46.95|
|52 Week Low||AU$31.96|
|1 Month Change||-0.91%|
|3 Month Change||-5.74%|
|1 Year Change||-19.23%|
|3 Year Change||21.23%|
|5 Year Change||50.25%|
|Change since IPO||33,540.00%|
Recent News & Updates
We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 62% Above Its Share Price
Does the June share price for Sonic Healthcare Limited ( ASX:SHL ) reflect what it's really worth? Today, we will...
Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Shareholders Would Enjoy A Repeat Of Sonic Healthcare's (ASX:SHL) Recent Growth In Returns
What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
A Look At The Fair Value Of Sonic Healthcare Limited (ASX:SHL)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Sonic Healthcare...
|SHL||AU Healthcare||AU Market|
Return vs Industry: SHL underperformed the Australian Healthcare industry which returned -9% over the past year.
Return vs Market: SHL underperformed the Australian Market which returned -8.5% over the past year.
|SHL Average Weekly Movement||3.5%|
|Healthcare Industry Average Movement||5.8%|
|Market Average Movement||10.6%|
|10% most volatile stocks in AU Market||18.1%|
|10% least volatile stocks in AU Market||4.6%|
Stable Share Price: SHL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: SHL's weekly volatility (3%) has been stable over the past year.
About the Company
Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners.
Sonic Healthcare Fundamentals Summary
|SHL fundamental statistics|
Is SHL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SHL income statement (TTM)|
|Cost of Revenue||AU$5.41b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 24, 2022
|Earnings per share (EPS)||3.11|
|Net Profit Margin||16.14%|
How did SHL perform over the long term?See historical performance and comparison
2.8%Current Dividend Yield
Is SHL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SHL?
Other financial metrics that can be useful for relative valuation.
|What is SHL's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does SHL's PE Ratio compare to its peers?
|SHL PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
ACL Australian Clinical Labs
IDX Integral Diagnostics
RHC Ramsay Health Care
SHL Sonic Healthcare
Price-To-Earnings vs Peers: SHL is good value based on its Price-To-Earnings Ratio (10.8x) compared to the peer average (23.2x).
Price to Earnings Ratio vs Industry
How does SHL's PE Ratio compare vs other companies in the Oceanian Healthcare Industry?
Price-To-Earnings vs Industry: SHL is good value based on its Price-To-Earnings Ratio (10.8x) compared to the Oceanic Healthcare industry average (26x)
Price to Earnings Ratio vs Fair Ratio
What is SHL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||10.8x|
|Fair PE Ratio||17.9x|
Price-To-Earnings vs Fair Ratio: SHL is good value based on its Price-To-Earnings Ratio (10.8x) compared to the estimated Fair Price-To-Earnings Ratio (17.9x).
Share Price vs Fair Value
What is the Fair Price of SHL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SHL (A$33.64) is trading below our estimate of fair value (A$52.23)
Significantly Below Fair Value: SHL is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Sonic Healthcare forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHL's earnings are forecast to decline over the next 3 years (-16.4% per year).
Earnings vs Market: SHL's earnings are forecast to decline over the next 3 years (-16.4% per year).
High Growth Earnings: SHL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SHL's revenue is expected to decline over the next 3 years (-1.2% per year).
High Growth Revenue: SHL's revenue is forecast to decline over the next 3 years (-1.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (10%).
Discover growth companies
How has Sonic Healthcare performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SHL has high quality earnings.
Growing Profit Margin: SHL's current net profit margins (16.1%) are higher than last year (12%).
Past Earnings Growth Analysis
Earnings Trend: SHL's earnings have grown significantly by 26.9% per year over the past 5 years.
Accelerating Growth: SHL's earnings growth over the past year (54.1%) exceeds its 5-year average (26.9% per year).
Earnings vs Industry: SHL earnings growth over the past year (54.1%) exceeded the Healthcare industry 39%.
Return on Equity
High ROE: SHL's Return on Equity (21%) is considered high.
Discover strong past performing companies
How is Sonic Healthcare's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SHL's short term assets (A$2.4B) exceed its short term liabilities (A$2.0B).
Long Term Liabilities: SHL's short term assets (A$2.4B) do not cover its long term liabilities (A$3.3B).
Debt to Equity History and Analysis
Debt Level: SHL's net debt to equity ratio (14.7%) is considered satisfactory.
Reducing Debt: SHL's debt to equity ratio has reduced from 71.9% to 24.9% over the past 5 years.
Debt Coverage: SHL's debt is well covered by operating cash flow (127%).
Interest Coverage: SHL's interest payments on its debt are well covered by EBIT (26.2x coverage).
Discover healthy companies
What is Sonic Healthcare current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SHL's dividend (2.82%) is higher than the bottom 25% of dividend payers in the Australian market (2.56%).
High Dividend: SHL's dividend (2.82%) is low compared to the top 25% of dividend payers in the Australian market (6.36%).
Stability and Growth of Payments
Stable Dividend: SHL's dividends per share have been stable in the past 10 years.
Growing Dividend: SHL's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31%), SHL's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (23.3%), SHL's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Colin Goldschmidt (68 yo)
Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...
CEO Compensation Analysis
Compensation vs Market: Colin's total compensation ($USD4.78M) is about average for companies of similar size in the Australian market ($USD4.20M).
Compensation vs Earnings: Colin's compensation has increased by more than 20% in the past year.
Experienced Management: SHL's management team is seasoned and experienced (21.6 years average tenure).
Experienced Board: SHL's board of directors are seasoned and experienced ( 12.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sonic Healthcare Limited's employee growth, exchange listings and data sources
- Name: Sonic Healthcare Limited
- Ticker: SHL
- Exchange: ASX
- Founded: 1934
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: AU$15.847b
- Shares outstanding: 471.77m
- Website: https://www.sonichealthcare.com
Number of Employees
- Sonic Healthcare Limited
- Grosvenor Place
- Level 22
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/15 00:00|
|End of Day Share Price||2022/08/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.